Edition:
United States

Boryung Pharm Co Ltd (003850.KS)

003850.KS on Korea Stock Exchange

48,950.00KRW
24 Mar 2017
Change (% chg)

₩200.00 (+0.41%)
Prev Close
₩48,750.00
Open
₩48,800.00
Day's High
₩49,100.00
Day's Low
₩48,550.00
Volume
15,733
Avg. Vol
27,206
52-wk High
₩68,813.70
52-wk Low
₩48,160.10

Latest Key Developments (Source: Significant Developments)

Boryung Pharm to pay annual dividend as 200 won/share for FY 2016
Thursday, 9 Mar 2017 09:24pm EST 

Boryung Pharm Co Ltd <003850.KS> : Says it will pay annual cash dividend as 200 won/share for FY 2016, to shareholders of record on Dec. 31, 2016 .Total dividend amount is 1.62 billion won.  Full Article

Boryung Pharm signs 82.97 bln won contract with Rampharma
Thursday, 29 Dec 2016 03:12am EST 

Boryung Pharm Co Ltd <003850.KS> : Says it signs 82.97 billion won contract with Rampharma to provide medicine .Says the contract period from Dec. 29 to Dec. 29, 2026.  Full Article

Boryung Pharm receives patent
Wednesday, 21 Dec 2016 12:34am EST 

Boryung Pharm Co Ltd <003850.KS> :Says it receives patent about cardiovascular disease medicine.  Full Article

Boryung Pharm sees 2016 full year revenue to be 420 bln won
Friday, 4 Nov 2016 01:26am EDT 

Boryung Pharm Co Ltd <003850.KS> :Sees 2016 full year revenue to be 420 billion won and operating profit to be 31 billion won.  Full Article

Pharma Mar and Boryung Pharm sign licensing deal for Aplidin in South Korea
Tuesday, 4 Oct 2016 03:57am EDT 

Pharma Mar SA : Pharma Mar and Boryung Pharm have signed a licensing agreement to commercialize the marine-derived anticancer drug Aplidin (plitidepsin) in South Korea . Under terms of the deal, Pharma Mar will receive an upfront payment, royalties and additional remunerations upon achieving regulatory milestones with Aplidin .PharmaMar will retain exclusive production rights and will supply the finished product to Boryung Pharm for commercial use.  Full Article

Boryung Pharm signs contract with STENDHAL
Sunday, 25 Sep 2016 10:16pm EDT 

Boryung Pharm Co Ltd <003850.KS> : Says it signs contract with STENDHAL, to provide goods .Contract amount of 30.04 billion won.  Full Article

Boryung Pharm receives patent
Tuesday, 9 Aug 2016 01:30am EDT 

Boryung Pharm <003850.KS> Co.,Ltd.:Says it receives patent on Aug. 9, for pharmaceutical composition of Fimasartan and Hydrochlorothiazide.  Full Article

Boryung Pharm to buy 32.7 pct stake in cell therapy product R&D firm for 1.5 bln won
Wednesday, 27 Jul 2016 10:38pm EDT 

Boryung Pharm <003850.KS> Co.,Ltd.:Says it will buy 32.7 percent stake (60,000 shares) in a cell therapy product R&D firm, for 1.5 billion won.  Full Article

BORYUNG PHARM announces patent granted
Wednesday, 20 Jul 2016 10:04pm EDT 

BORYUNG PHARM CO.,LTD <003850.KS>: Says it receives a patent, for pharmaceutical composition of fimasartan and hydrochlorothiazide .Says patent number of 2014/09508.  Full Article

Boryung Pharm receive patent
Monday, 18 Jul 2016 01:00am EDT 

Boryung Pharm <003850.KS> Co.,Ltd.:Says it receives patent on July 18, for antihypertensive pharmaceutical composition.  Full Article

More From Around the Web

BRIEF-Boryung Pharm to pay annual dividend as 200 won/share for FY 2016

* Says it will pay annual cash dividend as 200 won/share for FY 2016, to shareholders of record on Dec. 31, 2016